Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy.

Saved in:
Bibliographic Details
Title: Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy.
Authors: Kaulen LD; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center and German Consortium for Translational Cancer Research, Heidelberg, Germany., Martinez-Lage M; Division of Neuropathology, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Abramson JS; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Karschnia P; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Department of Neurosurgery, University Hospital of Friedrich-Alexander-University, Erlangen, Germany., Doubrovinskaia S; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center and German Consortium for Translational Cancer Research, Heidelberg, Germany., Shankar GM; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Choi BD; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Ramundo CM; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Ehret F; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium, Partner Site Berlin, a partnership between German Cancer Research Center and Charité Universitätsmedizin Berlin, Berlin, Germany., Barnes JA; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., El-Jawahri A; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Hochberg EP; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Johnson PC; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Soumerai JD; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Plotkin SR; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Batchelor TT; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Wick W; Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center and German Consortium for Translational Cancer Research, Heidelberg, Germany., Maus MV; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Cellular Immunotherapy Program, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Chen YB; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Frigault MJ; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Cellular Immunotherapy Program, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Dietrich J; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
Source: Blood [Blood] 2025 Oct 16; Vol. 146 (16), pp. 1902-1913.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood.2025028964